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Abstract
Alpha4 is a regulatory subunit of the protein phosphatase family of enzymes and plays an essential role in regulating the
catalytic subunit of PP2A (PP2Ac) within the rapamycin-sensitive signaling pathway. Alpha4 also interacts with MID1, a
microtubule-associated ubiquitin E3 ligase that appears to regulate the function of PP2A. The C-terminal region of alpha4
plays a key role in the binding interaction of PP2Ac and MID1. Here we report on the solution structure of a 45-amino acid
region derived from the C-terminus of alpha4 (alpha45) that binds tightly to MID1. In aqueous solution, alpha45 has
properties of an intrinsically unstructured peptide although chemical shift index and dihedral angle estimation based on
chemical shifts of backbone atoms indicate the presence of a transient a-helix. Alpha45 adopts a helix-turn-helix HEAT-like
structure in 1% SDS micelles, which may mimic a negatively charged surface for which alpha45 could bind. Alpha45 binds
tightly to the Bbox1 domain of MID1 in aqueous solution and adopts a structure consistent with the helix-turn-helix
structure observed in 1% SDS. The structure of alpha45 reveals two distinct surfaces, one that can interact with a negatively
charged surface, which is present on PP2A, and one that interacts with the Bbox1 domain of MID1.
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Introduction
Alpha4 was initially identified as an immunoglobin binding
protein (Ig-aBP) involved in signal transduction in mammalian B
and T lymphocytes [1,2,3,4,5]. Alpha4 and its yeast counterpart
Tap42 were later shown to be key regulators of protein
phosphatase 2A (PP2A) within the target of rapamycin (TOR)
signaling pathway [3,4,6,7,8,9,10,11]. Alpha4 binds to the
catalytic subunit of PP2A (PP2Ac) and displaces the scaffolding
and regulatory subunits that typically make up the PP2A
heterotrimeric complex [3,12,13,14,15]. Under growth-promoting
conditions TOR phosphorylates alpha4, which then binds and
down-regulates the function of PP2Ac [4,11]. The resulting
downstream activations of translation initiation factor 4E and S6
kinase initiate cell cycle progression [4,11]. In rapamycin-sensitive
cells, rapamycin promotes dissociation in the alpha4–PP2Ac
complex [4].
Alpha4 also interacts with MID1, a microtubule-associated
ubiquitin E3 ligase of the TRIM protein family [16]. MID1 is
postulated to facilitate the ubiquitination of PP2Ac [17,18,19,20].
Mutations of MID1 result in X-linked Opitz Syndrome (XLOS)
that is characterized by clefts lip/palate, wide-spaced eyes, and
hyperspadias [17,21,22,23,24,25,26,27]. Alpha4 co-expresses with
MID1 along the same tissues affected by XLOS [18,28].
Mutations of alpha4 result in overlapping MID1 birth defects
[29,30].
Alpha4 is postulated to be an important regulator of the
function of MID1 and PP2Ac. The MID1–alpha4–PP2Ac
complex results in either the dephosphorylation of MID1 and its
dissociation from the microtubules or the ubiquitination of PP2Ac
[17,25]. Overexpression of alpha4 results in the redistribution of
MID1 from the microtubule to the cytoplasm, suggesting that an
increase in the alpha4-PP2Ac complex promotes dephosphoryla-
tion of MID1 [17]. Deletion of the alpha4 gene locus results in an
increase in PP2Ac, indicating that the MID1-alpha4 complex is
important for PP2Ac turnover.
The X-ray structures of the N-terminal fragment of alpha4
(residues 1–221) and the related Tap42 (residues 1–234) were
recently determined [31,32]. The structures were shown to be
predominantly a-helical [31,32]. Attempts to clone full-length
alpha4 and Tap42 have resulted in truncated proteins with an N-
terminal region corresponding to the amino acids noted above [33].
While residues 94–202 of alpha4 are important for PP2Ac binding,
yeast two-hybrid studies indicated that deletion of the C-terminal
domain (236–339) dramatically decrease the binding to PP2A [4].
In addition, the C-terminal domain of alpha4 is responsible for
binding the Bbox1 domain of MID1 [25,26,34]. Thus, the C-
terminus is important for the overall function of alpha4, and its
structural characterization is important to gain insights into the
mechanism of function of alpha4. Within the C-terminal domain of
alpha4, a 45-amino acid region encompassing residues Glu236 to
Leu280 was shown to bind tightly to MID1 [34].
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e28877Here, we report on the NMR structures of the 45-amino acid
peptide (alpha45) in aqueous solution and in the presence of 1%
sodium dodecyl sulfate (SDS). These results suggest that the C-
terminus of alpha4 can undergo conformational changes based on
protein-protein interaction or its environment.
Materials and Methods
Cloning and purification
Native human alpha4 cDNA was used as the template to amplify
the region encoding residues Glu236 to Leu280 (alpha45). The
PCR fragment was cloned into the pMAL28 plasmid (New
England Biolabs, Inc) as a fusion protein with an N-terminal His6-
maltose-binding protein (MBP). The fusion protein is separated
from alpha45 by a tobacco etch virus protease (TEV) cleavage site.
The orientation and integrity of the vector were verified by DNA
sequencing prior to transformation into BL21(DE3) cells (Lucigen
Corp).
To obtain
15N and
15N/
13C-labeled His6-MBP-alpha45, cells
were grown in M9 minimal medium supplemented with
15N-
ammonium chloride (
15NH4Cl)/
12C-glucose or
15NH4Cl/
13C-
glucose, respectively. The cells were initially grown at 37uCt oa n
optical cell density of 0.6 and induced with 1 mM isopropyl-b-d-
thiogalactopyranoside (IPTG) for 12 hrs at 22uC. Cells were
harvested and stored at 280uC. For lysis, the cells were suspended
in 50 mM Tris-HCl buffer (pH 8), with 25% (w/v) sucrose,
phenylmethylsulfonyl fluoride (PMSF), protease inhibitors, lyso-
zyme (1 mg/ml), magnesium sulfate (0.5 mM), DNase (0.2 mg/
ml), 1% Triton-X 100 and 10 mM dithiothreitol (DTT) at 4uC,
and pulse sonicated. The lysate was centrifuged at 20,0006g and
the clarified supernatant was applied to the Ni
2+-NTA affinity
resin (Qiagen Inc.). The fusion protein was eluted with 50 mM
Tris–HCl (pH 8) containing 200 mM imidazole, cleaved with
TEV, and the peptide was purified by gel filtration.
NMR experiments
Two sets of NMR samples were prepared, one in which the
peptide was dissolved in aqueous solution and the other in which
1% SDS was added. The samples contained ,0.5 mM
15N- and
15N-
13C-labeled alpha45 in 50 mM Tris-HCl (pH 7.4), 0.2%
sodium azide in 90% H2O/10% D2O (with and without 1%
SDS). Data were acquired with Varian Inova 600 MHz spectrom-
eter equipped with a 5 mm triple resonance (
1H,
13C, and
15N)
probe with z-axis gradient. Double and triple resonance NMR
experiments were performed at 10uC for the aqueous samples. At
higher temperatures (.10uC) most of the NMR signals in the HN-
HN and HN-side-chain proton regions of the nuclear Overhauser
effect spectroscopy (NOESY) spectrum were missing, most likely
due to exchange of the NH protons with water. The data for the
sample in 1% SDS were acquired at 21 uC instead of 10uC because
the signals were sharper. Three-dimensional (3D)
1H-
15N-NOESY-
heteronuclear single quantum coherence (HSQC), and
1H-
13C-
HSQC-NOESY were acquired to identify
1H-
1H sequential and
Table 1. NMR Structure Determination Statistics.
Alpha45 in H2O Alpha45 in 1% SDS
A. Restraint Statistics
Intra-residue NOEs 82 163
Sequential NOEs (|i -j|=1) 42 147
Medium range NOEs (2#|i -j|#4) 58 88
Long range NOEs (|i -j|.4) 0 22
Total NOE restraints 182 416
Hydrogen bonds restraints 0 36
Dihedral angle restraints 58 62
Total Restraints 182 515
B. Ensemble Statistics Analysis
RMSD values (A ˚)
Backbone heavy atoms (helix I
a) 0.2660.09
b 0.1760.08
All heavy atoms (helix I) 1.2660.17 0.6760.13
Backbone heavy atoms (helix II
c) 0.3760.11
d 0.2160.07
All heavy atoms (helix II) 1.2860.21 0.9560.12
Backbone heavy atoms of helices I and II n/a 0.3860.10
All heavy atoms n/a 0.936 0.12
Statistics from Ramachandran plot
e
Residues in most favored regions (%) 88 83
Residues in additional allowed regions (%) 11 17
Residues in generously allowed regions (%) 0.7 0
Residues in disallowed regions (%) 0.3 0
aHelix I in SDS includes residues 243 to 254.
bHelix I in H2O includes 247–253.
cHelix II in SDS includes residues 264 to 277.
dHelix II in H2O includes residues 266 to 276.
eValue averaged for 14 structures.
doi:10.1371/journal.pone.0028877.t001
NMR Structure of alpha4 C-Terminus
PLoS ONE | www.plosone.org 2 December 2011 | Volume 6 | Issue 12 | e28877Figure 1. Secondary structure analysis of alpha45 in aqueous solution by NMR. A. HSQC spectrum of alpha45 in aqueous solution reveals
that the NH signals fall within 1 ppm of each other, suggesting a labile structure. The NH assignments were identified using the 3D NMR data. M*
represents one of the three amino acids that is the result from TEV cleavage; this residue is not part of alpha4 sequence. B. Strip plots taken from the
2D
1H-
1H projections from the
15N planes of the 3D
1H-
15N NOESY-HSQC spectrum showing NOE correlations between the NH(i) to intra-residue and
preceding Ha atoms (top panels) and sequential NH to NH atoms (bottom panels) for residues predicted to be helix II. An attempt to show NH-
NH(i,i61) NOE correlations is indicated by lines, but the NOEs are weak, ambiguous and mostly missing. C(i). Analysis of the Ca and Ha atom chemical
shift index (CSI) of alpha45 in aqueous solution. Upfield shifted Ca and simultaneous downfield shifted Ha values are indicative of a-helices. For the
peptide in aqueous solution, helix I cannot be definitively characterized because while the Ha values are upfield shifted, the Ca values are closer to
NMR Structure of alpha4 C-Terminus
PLoS ONE | www.plosone.org 3 December 2011 | Volume 6 | Issue 12 | e28877long range nuclear Overhauser effects (NOE) correlations using a
150 millisecond mixing time. The 3D-
1H-
15N HSQC-TOCSY
(50 msec) and
1H-
13C HCCH-TOCSY (15 msec) data were
acquired to assign through-bond correlations. The 3D HNCACB
and HNCA spectra were acquired to obtain backbone heteroatom
through-bond correlations.
The NMR data were processed with nmrPipe [35] and
analyzed with SPARKY3 [36]. NOEs were grouped as strong,
medium, or weak based on their intensities in the 3-D
15N- and
13C-edited NOESY spectra and assigned distance ranges of 1.8–
2.8 A ˚, 1.8–3.3 A ˚, and 1.8–5.0 A ˚, respectively. For alpha45 in 1%
SDS, hydrogen-bond restraints between the carbonyl and the
amide groups were defined with two distance restraints (O-H, 1.8–
2.5 A ˚ and O-N, 2.7–3.5 A ˚). Hydrogen bonds were established
from NOE patterns and the proximities of donor and acceptor
groups in initial structures calculated with only NOE-derived
restraints. The chemical shifts of the
1Ha, HN,
15N,
13Ca and
13Cb atoms were input into TALOS+ [37] for dihedral angle
estimation. The structures of alpha45 in aqueous solution and in
1% SDS were calculated with CYANA 2.1 [38]. The number of
restraints used in the structure calculations is listed in Table 1.
From a total of 50 randomly calculated structures, 14 structures
were selected based on low target functions (tf,1), and low root
mean standard deviation (RMSD) values (,1A ˚) for backbone and
heavy atom superposition. A total of 20,000 steps for torsion angle
simulated annealing were employed. The quality of the structures
was evaluated with Procheck [39].
To understand how the peptide interacted with the SDS
micelles, MnCl2 was titrated into 0.4 mM
15N-labeled alpha45 at
increments of 0.2 mM to a final concentration of 0.8 mM. HSQC
spectra were acquired at each increment. Amino acids that were
solvent exposed or could be in contact with Mn
2+ would have their
NMR signals broadened and disappear due to the paramagnetic
effect of the Mn
2+ ions, while those that interact with or may be
embedded in the micelles will have their signals protected. As
control, the titration was performed with alpha45 in aqueous
solution.
Bbox1-alpha45 Binding Studies by NMR
To determine whether Bbox1 and alpha45 interacted in
aqueous solution and to identify the residues involved in the
interaction,
1H-
15N HSQC spectra were acquired at 21uC. The
data were acquired at 21 uC instead of 10 uC because at the lower
temperature Bbox1 would aggregate causing the NMR signals of
both Bbox1 and Bbox1 bound alpha45 to broaden. First, 0.3 mM
unlabeled (
1H,
14N,
12C) Bbox1 was added to 0.3 mM
15N-labeled
alpha45. Second, unlabeled 0.15 mM alpha4 was added to
0.3 mM
15N-labeled Bbox1. The Bbox1 domain was purified as
described previously [40].
Results
Alpha45 is labile in aqueous solution
The two-dimensional
1H-
15N HSQC spectrum of alpha45 in
aqueous solution showed narrow dispersion (,1 ppm) of the NH
resonances, consistent with either a random coil or helical structure
(Figure 1A). Peaks representing 40 of the 45 amino acids were
observed and assigned to their corresponding amino acids using
three-dimensional NMR data; there were five proline residues,
which do not have N-H peaks. Sequential backbone
1H-
1H and
1H-
Ca(i)-Ca(i-1) atom correlations were made using the 3D
15N-HSQC-
NOESY and HNCA spectra, respectively. Even though this was a
45-amino acid peptide, which should give good through-band
correctly, the
1H-CaCb(i)-CaCb(i-1) correlations from the 3D
HNCACB spectrum were incomplete. Only
1H-Ca(i)-Ca(i-1)
correlations were observed, similar to those of the HNCA spectrum.
The HN-side-chain
1H-
1H correlations observed with the
15N-
edited NOESY spectrum and
1H-Ca(i)-Ca(i-1) connectivities with
the HNCA spectrum were sufficient to identify the amino acids.
Alpha45 was predicted to contain two a-helices between
residues Ile244 to Val254 and Val267 to Tyr277. Interestingly,
there were no strong intensity sequential HN-HN(i,i61) NOEs,
representing amino acids in helical conformations, observed for
any regions of the peptide (Figure 1B, bottom). At best, the HN-
HN(i,i61) NOEs were very weak and ambiguous, as depicted by
possible cross-peaks connected by lines within the NH region in
Figure 1B (bottom). Instead, strong intensity sequential
1HN-
Ha(i,i21) NOEs representing amino acids in an extended or b-
strand conformation were observed for the majority of the amino
acids (Figure 1B, top). Aside from the intra-residue HN to side-
chain proton NOE correlations, there were no medium or long-
range inter-residue (|i-j|.3) NOEs, indicating that the peptide
was highly extended, unstructured or highly labile. No side-chain
to side-chain proton NOEs were observed with the 3D
13C-
NOESY HSQC spectrum. Identification of ,90% of the side-
chain protons was made using the NOE cross-peak pattern from
the
13C- and
15N-NOESY spectra and the
15N-edited TOCSY
spectrum. The Cb chemical shifts were identified from intra-
residue
1H-
1H cross peak patterns from the
13C-edited NOESY
spectrum. In order to determine whether the lack of sequential or
long range NOEs from the
13C- or
15N-NOESY spectra was due
to incomplete NOE correlations, 2D
1H-
1H NOESY spectra were
acquired at various mixing times ranging from 50 to 800 ms.
However, no NOEs indicating medium and long range side-chain
1H-
1H interactions were observed.
CSI and TALOS+ reveal presence of an a-helix in aqueous
solution
Chemical shift indices (CSI) of backbone atoms can identify
secondary structural elements [41,42,43]. The chemical shift
values of the NH, N, Ha,C a and Cb atoms of non-proline amino
acids of alpha45 were compared to their random coil values
[44,45]. While the CSI of Cb and NH atoms can be consistent
with protein secondary structures, the CSI of Ca and Ha atoms
are more robust for identifying secondary structural elements
[41,43]. Thus, based on the CSI, the presence of one a-helical
segment was indicated (Figure 1C(i)). For the residues predicted to
be the first a-helix (residues 243–254), only the Ha chemical shifts
showed larger deviation from random coil values, while those of
the Ca and Cb resonances were much smaller (,0.4 ppm). In
contrast, the CSI values of both the Ha and Ca atoms for residues
predicted to be helix II (residues 264–276) were consistent with the
values observed for a-helices (Figure 1C(i)). The CSI values for the
Ca atoms were in the range of 3 ppm greater than random coil
values.
Chemical shift values of the NH, N, Ca,C b,H a, and Hb atoms
were input into TALOS+ to estimate the phi and psi dihedral
angles. TALOS+ uses a neural network that pre-classifies the
zero compared to those of helix II. C(ii). The phi (W, blue line) and psi (Y, red line) values and the order parameter (S
2, green line) are plotted for each
amino acid. These values were predicted by TALOS+ based on the chemical shift data. Residues adopting helical structure will have similar W and Y
values. The higher the S
2 values, the less mobile it is for that amino acid.
doi:10.1371/journal.pone.0028877.g001
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PLoS ONE | www.plosone.org 4 December 2011 | Volume 6 | Issue 12 | e28877Figure 2. Secondary structure of Alpha45 in 1% SDS. A. HSQC spectrum of alpha45 in 1% SDS shows changes in chemical shifts for ,60% of
the amino acids, most notably Tyr271 (boxed). The peaks are labeled to their corresponding amino acids based on assignments using the 3D NMR
data. B. Chemical shift differences of the NH and
15N atoms for alpha45 in 1% SDS compared to aqueous solution are shown to indicate amino acids
NMR Structure of alpha4 C-Terminus
PLoS ONE | www.plosone.org 5 December 2011 | Volume 6 | Issue 12 | e28877secondary structure into alpha and beta conformations and
calculates the random coil index (RCI) ‘order parameter’ to
identify residues with substantial dynamics. TALOS+ predicted
dihedral angles consistent with an a-helix for residues Thr264 to
Lys276 (Figure 1C (ii)). The predicted phi (W) and psi (Y) values
were plotted for each amino acid. Regions in which the W and Y
values are similar indicate a-helical structures. The order
parameters (RCI) representing the mobility of the N-H bond
vector were plotted for each amino acid (Figure 1C(ii)). Interest-
ingly, residues Arg247 to Ala252 had W and Y values consistent
with an a-helix, but their RCI values were shown to be
,0.4560.2, indicating these residues were highly labile and may
not exist in an a-helix in solution. In contrast, residues Val267 to
Lys276 had Y and W values consistent with an a-helix and RCI
values ranging from 0.7 to 0.9, suggesting that the C-terminal helix
may exist in a relatively stable but transient state in aqueous
solution.
Alpha45 adopts two stable a-helices in 1% SDS
With the observation that alpha45 was structurally labile in
aqueous solution but may possess helical segments, the peptide was
subjected to different conditions to determine whether its
secondary and tertiary structures could be stabilized. SDS was
found to be the best stabilizer. Previous reports have shown that
SDS can induce or stabilize structures of short peptides [46,47].
Upon adding 1% SDS to the NMR sample, large chemical shift
changes were observed with the
1H-
15N HSQC spectrum
(Figures 2A, B). Normalizing the NH and
15N shifts to the
equation [((DdNH)
2 + (0.2*DdN)
2)
1/2] [48], greater chemical shift
changes were observed for residues within the N-terminal half of
the peptide (Val240 to Lys253, Figure 2B). The stability of the
peptide in 1% SDS was confirmed by raising the temperature of
the sample from 21 to 37uC and monitoring the structure by
HSQC spectroscopy. After re-referencing the peak positions to
account for temperature effect, the chemical shifts of all the amino
acids remained unchanged, indicating the structure of the peptide
was stable in 1% SDS. At the lower temperature (10uC), the
resonances became broadened due to slower tumbling rate of the
SDS-peptide complex and not conducive for NMR analysis.
Similar to alpha45 in aqueous solution, the NMR signals of 40
of the 45 amino acids were assigned. Strong intensity HN-
HN(i61,2,3) and weaker HN-Ha(i–.124) NOEs, indicative of helical
structures, were observed for residues Phe243 to Phe255 and
Thr264 to Tyr277 (Figure 2C). Compared to alpha45 in aqueous
solution (Figure 1B), the HN-HN(i,i61) proton NOEs for residues
Thr264 to Tyr277 were more dispersed and significantly stronger
in intensity (Figure 2C). CSI and dihedral angle values estimated
with TALOS+ were consistent with the NOE-derived secondary
structural elements (Figure 2D(i, ii)). For residues of both helices,
the RCI values were .0.7, indicating stable secondary structures
(Figure 2D (ii)).
In contrast of alpha45 in aqueous solution for which the NMR
data showed a lack of side-chain to side-chain proton NOEs, the
1H-
13C-HSQC-NOESY data revealed numerous long range (|i-
j|.4) NOEs. The position of the two helices with respect to each
other was defined by 22 non-redundant long-range NOEs between
11 residues (Figure 3A).
Structure description of alpha45
A summary of the restraint input data and statistics of the
calculated structures are listed in Table 1. The structures with the
lowest target function values (,1.0), NOE violations ,0.15 A ˚,
dihedral angles ,2u, and van der Waals violations ,0.2 A ˚ were
selected. For alpha45 in aqueous solution, the ensemble of
structures generated did not yield tertiary structures that were
superimposable, even though restraints for strong intensity NH-
Ha(i21) NOEs were used in the initial calculation. When dihedral
angles for 29 amino acids were added to the calculation, two a-
helices were defined for residues Arg247 to Val254 and Thr266 to
Lys276 (structure not shown). Superposition of backbone atoms for
N- and C-terminal helices resulted in root-mean square deviation
(RMSD) values of 0.3760.11 and 0.2660.09 A ˚, respectively
(Table 1). Since the peptide may be labile in aqueous solution, the
structure may simply reflect a sampling of the actual conformation
of the peptide as it undergoes folded-unfolded transition. The
relative position of the two helices could not be defined due to lack
of long range NOEs.
The calculated structures of alpha45 based on restraints
acquired in 1% SDS showed two well-defined a-helices between
residues Phe243 to Phe255 and Thr264 to Tyr277 (Figure 3).
The RMSD values of the superposition of the backbone N, Ca,
C atoms for N-terminal and C-terminal helices were
0.1760.08 A ˚ and 0.2160.07 A ˚, respectively (Figure 3B,
Table 1). The structured loop between the helices included
residues Phe255 to Pro263. The RMSD value for the
superposition of the backbone N, Ca, C atoms of the two
helices was 0.3860.10 A ˚, while that for all heavy atoms was
0.8860.12 A ˚ (Table 1). The RMSD value of superposition of
backbone atoms for residues 240 to 277, for which there were
sequential and long-range NOEs, was 0.5960.20 A ˚, indicating
that the overall structure of alpha45 was very well-defined
(Figure 3C). The ribbon representations of alpha45 (Figure 3C)
show that the position of the helices is slightly offset by about half
a helical turn, with the C-terminal end of helix I making contact
with residues of the structured loop.
Alpha45 interacts electrostatically with SDS micelles
Paramagnetic studies were performed to determine how SDS
might interact with alpha4 and stabilize its structure (Figure 4A).
Thirty residues were observed to have their
1H-
15NH S Q Cp e a k s
protected from the paramagnetic effects of Mn
2+:A r g 2 3 7 ,
Lys241, Phe243 to Tyr259, Ser261, Leu262, Thr264, Met265,
Val267, Tyr271, and Val274 to Gly278. In contrast, Mn
2+
broadened the NH signals of 10 residues that included Glu236,
Val240, Thr266, Ser268 to Trp270, Glu272 to His274 and
Leu280. The remaining five residues were prolines that do not
have NH signals.
Interestingly, the paramagnetic protection data for alpha45 in
aqueous solution revealed 19 of the 30 residues protected in the
that were most sensitive to the presence of SDS. The NH and
15N shifts are normalized to the equation [((DdNH)
2 + (0.2*DdN)
2)
1/2]. Larger chemical
shift changes were observed for residues within the first half of alpha45, based on Dd.0.5 p.p.m. C. Strip plots taken from the 2D
1H-
1H projections
from the
15N planes of the 3D NOESY HSQC spectrum show strong intensity NH-NH(i,i61) NOEs for residues Val267 to Glu272 in 1% SDS. These
residues are part of helix II. The corresponding NH(i) to intra-residue and preceding Ha atoms are also shown (top panels). Compared to Figure 1B, the
sequential NH-NH signals are dispersed, strong, and unambiguous. D(i). The CSI of the Ca and Ha atoms of alpha45 in 1% SDS reveal upfield shifted
Ca and simultaneous downfield shifted Ha values, indicative of two a-helices. D(ii). The phi (W, blue line) and psi (Y, red line) values and the order
parameter (S
2, green line) are plotted for each amino acid. The W and Y values are consistent with the CSI values, while the S
2 values, in the range of
0.7 to 0.9, indicate stability for the two helices.
doi:10.1371/journal.pone.0028877.g002
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PLoS ONE | www.plosone.org 7 December 2011 | Volume 6 | Issue 12 | e28877SDS sample had their signals unaffected (data not shown). This
comparison showed that Lys241, Phe243, Arg247, Ser261,
Leu262, Thr264, Val267, Tyr271, Val274, Arg275 and Lys276
were the only residues protected by 1% SDS. There were no
amino acids whose NH signals were protected in aqueous solution
but disappeared in 1% SDS.
Figure 3. Structure of alpha45. A. Stripplotstakenfromthe2D
1H-
1Hprojectionsofthe
13Cplanesofthe 3D-
1H-
13C-editedHSQC-NOESYshowlong
range NOEs between residues Val267 with Leu245 and Thr246, and between Thr246 and Tyr271, which were used in the tertiary structural calculation of
alpha45. All intra-residue NOEs are labeled on the figure and arrows indicate inter-residues NOEs. In this modified version of the
13C-edited NOESY
spectrum, the diagonal auto-peaks were suppressed. B. Superposition of the backbone Ca, C, N atoms for residues 243 to 277 of fourteen structures of
alpha45 calculated based on NMR restraints acquired in 1% SDS. The backbone atoms of the two a-helices are colored red (see Table 1). C. Ribbon
representation of the structure of alpha45 in 1% SDS. For clarity, two orientations of the structure are shown using the same color scheme noted above.
doi:10.1371/journal.pone.0028877.g003
Figure 4. Paramagnetic effect on alpha45. A. Superposition of the
1H-
15N HSQC spectra of alpha45 in 1% SDS (black) and in 1% SDS with 46
excess MnCl2 (red). Amino acids that are solvent exposed and/or accessible to Mn
2+ had their
1H-
15N signals broadened. Those amino acids are
labeled. B. Ribbon representation of alpha45 shows the location of the basic residues that were most protected from the paramagnetic effects in 1%
SDS. The regions colored in green represent the amino acids that were protected from paramagnetic effect only in SDS but not in aqueous solution.
The residues whose NH signals were affected by Mn
2+ in both SDS and aqueous solution are shown in red and found to be located on the outer
surface of helix II C. Two views of the electrostatic map of alpha45. The blue represents basic patches and red indicates acid patches. The orientation
of the left image is the same as that shown in ‘B’. The map was generated by PBEQ-solver [59,60].
doi:10.1371/journal.pone.0028877.g004
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PLoS ONE | www.plosone.org 8 December 2011 | Volume 6 | Issue 12 | e28877Based on the tertiary structure of alpha45 and the pattern of
paramagnetic protection, it is unlikely that the peptide was
embedded into the micelles. Instead it most likely existed in a state
close to its actual 3D structure. Since the NOE cross-peak patterns
indicated that the N-terminal half of alpha45 was unstructured in
aqueous solution, the protection of these residues was probably due
to soluble protein aggregation. The residues protected only in SDS
were at the N-terminal end of helix I and at the C-terminal end of
helix II, and located on one surface of alpha4 (Figure 4B), indicating
that their interaction with each other but more importantly with the
SDS micelles helped to stabilize the secondary and tertiary structure
ofthepeptide.Amongtheseresiduesaretwolysineand twoarginine
residues that form a basic patch on one surface of alpha45
(Figures 4B,C), suggesting that electrostatic interaction with the
negatively charged surface of the SDS micelles may be important
for stabilizing the helix-loop-helix structure of alpha45. Interesting-
ly, only residues on the outer surface of helix II were most
unprotected from the paramagnetic effects (Figure 4B).
Figure 5. Interaction of alpha45 and the MID1 Bbox1 domain. A. Superposition of the
1H-
15N HSQC spectra of free
15N-labeled alpha45
(black) and
15N-labeled alpha45 (red) in the presence of 1:1 ratio of unlabeled Bbox1 in aqueous solution. Amino acids of alpha45 whose NH peaks
showed chemical shift changes due to interaction are labeled. B. Ribbon representation of alpha45 indicates the location and residues that showed
chemical shift changes when Bbox1 was added. C. Superposition of the
1H-
15N HSQC spectra of free
15N-labeled Bbox1 (black) and
15N-labeled Bbox1
with unlabeled alpha45 (red). The ratio of Bbox1 to alpha45 was 1:0.5. In additions to peak shifts, new peaks with intensities corresponding to ,0.5
that of the original peak were observed at different locations, indicating Bbox1 existed in two slow exchanging states: free and bound. D. Surface and
ribbon representations of the MID1 Bbox1 domain showing the residues that underwent chemical shift changes when alpha45 was bound. Basic and
acidic residues are colored blue and red, respectively, while hydrophobic residues are colored green. Polar residues are colored cyan.
doi:10.1371/journal.pone.0028877.g005
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To confirm that alpha45 and the Bbox1 domain can interact,
1H-
15N-HSQC spectra were acquired for
15N-labeled alpha45 in
the presence of unlabeled Bbox1, and then for
15N-labeled Bbox1
in the presence of unlabeled alpha45. For alpha45, chemical shift
changes indicating interaction were observed for residues Asn248,
Met249, Ser261, Thr264, Thr266, Ser268, Asp269, Gln273,
His274, and Lys276 (Figure 5A). With the exception of Asn248
and Met249, these residues were predicted by CSI and TALOS+
to be helical, and were indeed found to be part of helix II in 1%
SDS (Figure 5B). In addition, some of these residues were also
susceptible to paramagnetic effect, suggesting they were solvent
exposed and on a surface distinct from the SDS interacting
surface. With the exception of Asn248 and Met249, the amino
acids of the N-terminal half of alpha45 did not show significant
chemical shift changes, indicating that they did not interact with
the Bbox1 domain. The HSQC spectrum of alpha45 in the
presence of the Bbox1 domain was similar to that of alpha45 in
1% SDS, suggesting the presence of two helices.
For the Bbox1 domain, both chemical shift changes as well as
the appearance of new signals were observed (Figure 5C). These
observations suggested that the binding was strong, and that a
subset of Bbox1 (,40–50%) was coordinated to alpha45. The
intensities of peaks corresponding to residues Lys132, Thr133,
Cys142, Asp143, Glu144, Cys145, Lys147, Lys153, and Ile162
were decreased by ,50%, consistent with ,50% of Bbox1
forming a tight 1:1 complex with alpha45 (Figure 5C). These
residues are clustered on one surface of the Bbox1 domain
(Figure 5D).
Discussion
The NMR studies of the MID1-binding region of alpha4 reveal
that the 45-amino acid portion of the C-terminus has properties of
an intrinsically unstructured peptide or protein. Intrinsically
unstructured proteins (IUP) do not typically adopt regular
secondary or tertiary structures in solution but become structured
in the presence of their binding partner (reviews in [49,50,51]).
The IUP phenomenon is widely recognized in all organisms to
play a significant role in regulating protein function and signal
transduction [49,50,51]. For instance, the C-terminal 100 amino
acids of the cell cycle regulator p27 (Kip1) are intrinsically
unstructured and this affords p27 the flexibility to mediate
phosphorylation and ubiquitination events of cyclin-dependent
kinases [50]. Similarly, the intrinsically unstructured properties of
the peptide inhibitors, I-2 and DARPP-32, of protein phospha-
tase1 (PP1) enable the peptides to make extensive contacts with
PP1 invariant surfaces [52]. Similarly these properties could afford
the C-terminus of alpha4 the flexibility and specificity to bind
MID1 and PP2Ac and modulate their relative positions to each
other, thereby mediating the dephosphorylation of MID1 and/or
ubiquitination of PP2Ac.
The indication of the presence of a-helices by CSI and dihedral
angles suggests that alpha45 may be sampling its folded-unfolded
states. The addition of 1% SDS stabilizes the secondary and
tertiary structure of the peptide via key interaction with two lysine
and two arginine residues located at the ends of the two helices.
Although this observation does not confirm that alpha4 is
membrane-associated, expression of fluorescent-tagged alpha4 in
COS1 cells depicted alpha4 to be localized proximal to the plasma
membrane (20,28). Alpha4 appears to target PP2A that regulates
the E-cadherin–b-catenin complex [21,25]. E-cadherins are
transmembrane proteins that bind b-catenin, which is part of
the Wnt signaling pathway. The interaction with b-catenin is
mediated by phosphorylation. It is postulated that loss of function
of MID1 or alpha4 results in an increase of PP2A and an increase
in the dephosphorylation of E-cadherins. As a result, cell-cell
adhesion is disrupted possibly explaining structural abnormalities
observed in XLOS [17,21,25,26,27].
The negatively charged head-group (SO4
2) of the SDS micelles
may mimic a large negatively charged surface of an alpha4
binding partner. The structure of alpha45 revealed a basic patch,
consisting of Arg237, Lys241, Arg247, Arg275, and Lys276,
located near the N-terminal half of helix I (Figures 4B, 6A). As it
turns out, the structure of PP2A, consisting of A- (PR65), B-
(regulatory) and C- (catalytic) subunits (pdb accession code 3DW8
[53]), revealed a very large negative patch on PR65 that closely
mimics the negative surface of the SDS micelles (Figure 6B). In the
Figure 6. Proposed surfaces of interaction. A. Surface depiction of
the two binding interfaces of alpha45 that could interact with the
Bbox1 domain and PP2A simultaneously. B. Ribbon representation of
the A- (scaffolding (PR65), colored gray) and C- (catalytic, colored
yellow) subunits of PP2A, pdb accession code 3DW8. PR65 adopts a
helix-turn-helix HEAT repeat structure. All glutamic and aspartic acids
are shown in red on the A(PR65)-subunit. Located near the N-terminus
of PR65 is a large negative patch, depicted by surface representation
(colored red) that could accommodate the positively charged surface of
alpha45. This is also the same surface on which the B- (regulatory, B55)
subunit of PP2A binds. The alpha4 N-terminal binding site on PP2Ac is
shown in orange.
doi:10.1371/journal.pone.0028877.g006
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omitted, binds directly over the large negative surface located near
the N-terminus. We postulate that the C-terminus of alpha4 can
also bind this surface. Mutation of a key glutamate residue was
found to disrupt alpha4 interaction [54,55]. The helix-turn-helix
structure of alpha45 also closely matches the helix-turn-helix
HEAT repeats of the PR65/scaffolding subunit [56]. In contrast,
the region of B55 that interacts with the large negative patch of
PR65 adopts a b-sheet structure. Thus, the HEAT-like structure of
alpha45 may allow the C-terminal region of alpha4 to integrate
itself into the existing structure of PR65 and thus play a key role in
displacing the regulatory subunit. This interaction will allow the
N-terminal region of alpha4 (residues 1–221) to interact with the
catalytic subunit of PP2A (PP2Ac). The key site on PP2Ac on
which the N-terminal domain of alpha4 interacts involves an a-
helix (colored orange on Figure 6B). This region of PP2Ac is
exposed and can accommodate the N-terminus of alpha4, while
the C-terminus of alpha4 can easily reach the negatively charged
surface of PR65 (Figure 6B). The interaction of both the N- and C-
terminal domains of alpha4 with PP2A is essential for the
regulation of PP2A [31].
The residues of alpha45 that form the binding surface with
Bbox1 are found along helix II and located opposite to the basic
patch that would be involved in the PP2A interaction (Figures 5B,
6A). These residues can only be involved in binding the Bbox1
domain if they are part of the helix-loop-helix structure observed
in 1% SDS. Thus, alpha4 undergoes a significant conformational
change when Bbox1 is present. Alpha45 interacts with Lys132,
Thr133, Asp143, Glu144, Lys147, Lys153 and Ile162 of Bbox1
(Figure 5D). These residues are located on one surface of Bbox1
and can easily interact with the charged and polar residues located
along helix II of alpha45. Interestingly, two key lysine residues
located at the C-terminal end of the helix (Lys147) and on the loop
(Lys153, whose positions could not be defined in the free protein
[40]), show significant chemical shift changes in the HSQC
spectrum when alpha45 was added. The movement of this loop
with the lysine may be key for forming the interface with alpha45.
Lysine153 is next to Lys154, which is poly-ubiquitinated in MID1
[16]. In our ubiquitination studies of MID1, the addition of
alpha45 significantly attenuated the autoubiquitination of the
Bbox1 domain, suggesting that by binding and sequestering
Lys153, alpha45 prevented or weakened the interaction of Bbox1
with the E2 conjugating enzyme [16].
In yeast two-hybrid studies probing the interaction of MID1
and alpha4, it was demonstrated that alpha4 bound Bbox1 most
tightly as a single domain [57]. When the MID1 construct
included Bbox2, the interaction with alpha4 decreased substan-
tially, suggesting that Bbox2 attenuates alpha4 binding. Residues
Lys132, Thr133, Ile162 of Bbox1 that form part of the binding
surface with alpha45 are also involved in binding Bbox2 [58]. This
observation may explain why the presence of Bbox2 could weaken
the interaction between Bbox1 and alpha4 [57,58].
In summary, the C-terminal peptide of alpha4 appears to be
intrinsically unstructured but possesses the structural information
that is induced upon its interaction with the Bbox1 and SDS
micelles. Upon adopting a helix-turn-helix structure, the peptide
maintains two distinct surfaces that could interact with both Bbox1
domain and a negatively charged surface of PP2Ac. By binding the
Bbox1 domain, the RING domain of MID1, which functions as an
E3 ligase, could be placed in close proximity in order to facilitate
the ubiquitination of PP2Ac.
Acknowledgments
We give thanks to Robert Edwards for help with acquiring NMR data, and
to Dr. Michael F. Summers (University of Maryland Baltimore County) for
allowing us to acquire the
13C-edited NOESY spectra on his 600 MHz
Bruker NMR spectrometer equipped with a CryoProbe.
Author Contributions
Conceived and designed the experiments: HD MM. Performed the
experiments: HD MM. Analyzed the data: HD MM. Contributed
reagents/materials/analysis tools: HD MM. Wrote the paper: HD MM.
References
1. Chuang E, Fisher TS, Morgan RW, Robbins MD, Duerr JM, et al. (2000) The
CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase
PP2A. Immunity 13: 313–322.
2. Inui S, Kuwahara K, Mizutani J, Maeda K, Kawai T, et al. (1995) Molecular
cloning of a cDNA clone encoding a phosphoprotein component related to the
Ig receptor-mediated signal transduction. J Immunol 154: 2714–2723.
3. Murata K, Wu J, Brautigan DL (1997) B cell receptor-associated protein alpha-4
displays rapamycin-sensitive binding directly to the catalytic subunit of protein
phosphatase 2A. Proc Natl Acad Sci U S A 94: 10624–10629.
4. Inui S, Sanjo H, Maeda K, Yamamoto H, Miyamoto E, et al. (1998) Ig receptor
binding protein 1 (alpha4) is associated with a rapamycin-sensitive signal
transduction in lymphocytes through direct binding to the catalytic subunit of
protein phosphatase 2A. Blood 92: 539–546.
5. Onda M, Inui S, Maeda K, Suzuki M, Takahashi E, et al. (1997) Expression and
chromosomal localization of the human alpha 4/IGBP1 gene, the structure of
which is closely related to the yeast TAP42 protein of the rapamycin-sensitive
signal transduction pathway. Genomics 46: 373–378.
6. Cygnar KD, Gao X, Pan D, Neufeld TP (2005) The phosphatase subunit tap42
functions independently of target of rapamycin to regulate cell division and
survival in Drosophila. Genetics 170: 733–740.
7. Jiang Y, Broach JR (1999) Tor proteins and protein phosphatase 2A reciprocally
regulate Tap42 in controlling cell growth in yeast. Embo J 18: 2782–2792.
8. Dutcher JP (2004) Mammalian target of rapamycin (mTOR) Inhibitors. Curr
Oncol Rep 6: 111–115.
9. Mita MM, Mita A, Rowinsky EK (2003) Mammalian target of rapamycin: a new
molecular target for breast cancer. Clin Breast Cancer 4: 126–137.
10. Rao RD, Buckner JC, Sarkaria JN (2004) Mammalian target of rapamycin
(mTOR) inhibitors as anti-cancer agents. Curr Cancer Drug Targets 4: 621–635.
11. Smetana JH, Oliveira CL, Jablonka W, Aguiar Pertinhez T, Carneiro FR, et al.
(2006) Low resolution structure of the human alpha4 protein (IgBP1) and studies
on the stability of alpha4 and of its yeast ortholog Tap42. Biochim Biophys Acta
1764: 724–734.
12. Sontag E (2001) Protein phosphatase 2A: the Trogan Horse of cellular signaling.
Cellular Signalling 13: 7–11.
13. Turowski P, Favre B, Campbell KS, Lamb NJ, Hemmings BA (1997)
Modulation of the enzymatic properties of protein phosphatase 2A catalytic
subunit by the recombinant 65-kDa regulatory subunit PR65alpha.
Eur J Biochem 248: 200–208.
14. Kremmer E, Ohst K, Kiefer J, Brewis N, Walter G (1997) Separation of PP2A core
enzyme and holoenzyme with monoclonal antibodies against the regulatory A
subunit: abundant expression of both forms in cells. Mol Cell Biol 17: 1692–1701.
15. Mayer-Jaekel RE, Hemmings BA (1994) Protein phosphatase 2A–a ‘menage a
trois’. Trends Cell Biol 4: 287–291.
16. Han X, Du H, Massiah MA (2011) Detection and characterization of the in vitro
e3 ligase activity of the human MID1 protein. Journal of Molecular Biology 407:
505–520.
17. Trockenbacher A, Suckow V, Foerster J, Winter J, Krauss S, et al. (2001) MID1,
mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase
2A for degradation. Nat Genet 29: 287–294.
18. Liu J, Prickett TD, Elliott E, Meroni G, Brautigan DL (2001) Phosphorylation
and microtubule association of the Opitz syndrome protein mid-1 is regulated by
protein phosphatase 2A via binding to the regulatory subunit alpha 4. Proc Natl
Acad Sci U S A 98: 6650–6655.
19. Schweiger S, Foerster J, Lehmann T, Suckow V, Muller YA, et al. (1999) The
Opitz syndrome gene product, MID1, associates with microtubules. Proc Natl
Acad Sci U S A 96: 2794–2799.
20. Short KM, Cox TC (2006) Sub-classification of the rbcc/trim superfamily
reveals a novel motif necessary for microtubule binding. J Biol Chem.
21. Cox T (2004) Taking it to the max: The genetic and developmental mechanisms
coordinating midfacial morphogenesis and dysmorphology. Clin Genet 65:
163–176.
22. Gaudenz K, Roessler E, Quaderi N, Franco B, Feldman G, et al. (1998) Opitz
G/BBB syndrome in Xp22: mutations in the MID1 gene cluster in the carboxy-
terminal domain. Am J Hum Genet 63: 703–710.
NMR Structure of alpha4 C-Terminus
PLoS ONE | www.plosone.org 11 December 2011 | Volume 6 | Issue 12 | e2887723. Granata A, Quaderi NA (2003) The Opitz syndrome gene MID1 is essential for
establishing asymmetric gene expression in Hensen’s node. Dev Biol 258:
397–405.
24. Quaderi NA, Schweiger S, Gaudenz K, Franco B, Rugarli EI, et al. (1997) Opitz
G/BBB syndrome, a defect of midline development, is due to mutations in a new
RING finger gene on Xp22. Nat Genet 17: 285–291.
25. Schweiger S, Schneider R (2003) The MID1/PP2A complex: a key to the
pathogenesis of Opitz BBB/G syndrome. Bioessays 25: 356–366.
26. Cox TC, Allen LR, Cox LL, Hopwood B, Goodwin B, et al. (2000) New
mutations in MID1 provide support for loss of function as the cause of X-linked
Opitz syndrome. Hum Mol Genet 9: 2553–2562.
27. Short KM, Hopwood B, Yi Z, Cox TC (2002) Mid1 and Mid2 homo- and
heterodimerise to tether the rapamycin-sensitive PP2A regulatory subunit, Alpha
4, to microtubules: implications for the clinical variability of X-linked Opitz
GBBB syndrome and other developmental disorders. BMC Cell Biology 3: 1–14.
28. Everett AD, Brautigan DL (2002) Developmental Expresssion of alpha4 protein
phosphase regulatory subunit in tissues affected by Opitz syndrome. Develop-
mental Dynamics 224: 461–464.
29. De Falco F, Cainarca S, Andolfi G, Ferrentino R, Berti C, et al. (2003) X-linked
Opitz syndrome: novel mutations in the MID1 gene and redefinition of the
clinical spectrum. Am J Med Genet A 120A: 222–228.
30. Graham JM, Jr., Wheeler P, Tackels-Horne D, Lin AE, Hall BD, et al. (2003) A
new X-linked syndrome with agenesis of the corpus callosum, mental
retardation, coloboma, micrognathia, and a mutation in the Alpha 4 gene at
Xq13. Am J Med Genet A 123A: 37–44.
31. LeNoue-Newton M, Watkins GR, Zou P, Germane KL, McCorvey LR, et al.
(2011) The E3 ubiquitin ligase- and protein phosphatase 2A (PP2A)-binding
domains of the Alpha4 protein are both required for Alpha4 to inhibit PP2A
degradation. The Journal of biological chemistry 286: 17665–17671.
32. Yang J, Roe SM, Prickett TD, Brautigan DL, Barford D (2007) The structure of
Tap42/alpha4 reveals a tetratricopeptide repeat-like fold and provides insights
into PP2A regulation. Biochemistry 46: 8807–8815.
33. Smetana JHC, Oliveira CLP, Jablonka W, Pertinhez TA, Carneiro FRG, et al.
(2006) Low Resolution Structure of the Human alpha4 protein (IgBP1) and
studies on the stability of alpha4 and its yeast ortholog Tap42. Biochim Biophys
Acta 1764: 724–734.
34. Aranda-Orgilles B, Trockenbacher A, Winter J, Aigner J, Kohler A, et al. (2008)
The Opitz syndrome gene product MID1 assembles a microtubule-associated
ribonucleoprotein complex. Hum Genet 123: 163–176.
35. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, et al. (1995) NMRPipe: a
multidimensional spectral processing system based on UNIX pipes. J Biomol
NMR 6: 277–293.
36. Goddard TD, Kneller DG. SPARKY 3. University of Californa, San Fancisco.
37. Cornilescu G, Delaglio F, Bax A (1999) Protein backbone angle restraints from
searching a database for chemical shift and sequence homology. J Biomol NMR
13: 289–302.
38. Guntert P (2004) Automated NMR structure calculation with CYANA. Methods
Mol Biol 278: 353–378.
39. Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1993) PROCHECK:
a program to check the stereochemical quality of protein structures. J Appl Cryst
26: 283–291.
40. Massiah MA, Simmons BN, Short KM, Cox TC (2006) Solution structure of the
RBCC/TRIM B-box1 domain of human MID1: B-box with a RING. J Mol
Biol 358: 532–545.
41. Wishart DS, Sykes BD (1994) The 13C chemical-shift index: a simple method
for the identification of protein secondary structure using the 13C chemical-shift
data. J Biomol NMR 222: 311–333.
42. Andersen NH, Cao B, Chen C (1992) Peptide/protein structure analysis using
the chemical shift index method: upfield alpha-CH values reveal dynamic helices
and alpha L sites. Biochemical and biophysical research communications 184:
1008–1014.
43. Wishart DS, Sykes BD, Richards FM (1992) The chemical shift index: a fast and
simple method for the assignment of protein secondary structure through NMR
spectroscopy. Biochemistry 31: 1647–1651.
44. Lee MS, Palmer AG, Wright PE (1992) Relationship between 1H and 13C
NMR chemcial shifts and the secondary and tertiary structure of a zinc finger
peptide. J Biomol NMR 2: 307–322.
45. Schwarzinger S, Kroon GJA, Foss TR, Wright PE, Dyson HJ (2000) Random
coil chemical shifts in acidic 8 M urea: implementation of random coil shift data
in NMRView. J Biomol NMR 18: 43–48.
46. Parker W, Song PS (1992) Protein structures in SDS micelle-protein complexes.
Biophys J 61: 1435–1439.
47. Bystrom R, Aisenbrey C, Borowik T, Bokvist M, Lindstrom F, et al. (2008)
Disordered proteins: biological membranes as two-dimensional aggregation
matrices. Cell Biochem Biophys 52: 175–189.
48. Hiller S, Garces RG, Malia TJ, Orekhov VY, Colombini M, et al. (2008)
Solution structure of the integral human membrane protein VDAC-1 in
detergent micelles. Science 321: 1206–1210.
49. Dunker AK, Oldfield CJ, Meng J, Romero P, Yang JY, et al. (2008) The
unfoldomics decade: an update on intrinsically disordered proteins. BMC
Genomics 9 Suppl 2: S1.
50. Galea CA, Nourse A, Wang Y, Sivakolundu SG, Heller WT, et al. (2008) Role
of intrinsic flexibility in signal transduction mediated by the cell cycle regulator,
p27 Kip1. J Mol Biol 376: 827–838.
51. Galea CA, Wang Y, Sivakolundu SG, Kriwacki RW (2008) Regulation of cell
division by intrinsically unstructured proteins: intrinsic flexibility, modularity,
and signaling conduits. Biochemistry 47: 7598–7609.
52. Dancheck B, Nairn AC, Peti W (2008) Detailed Structural Characterization of
Unbound Protein Phosphatase 1 Inhibitors. Biochemistry.
53. Xu Y, Chen Y, Zhang P, Jeffrey PD, Shi Y (2008) Structure of a protein
phosphatase 2A holoenzyme: insights into B55-mediated Tau dephosphoryla-
tion. Molecular cell 31: 873–885.
54. Yang J, Roe SM, Prickett TD, Brautigan DL, Barford D (2007) The Structure of
Tap42/alpha4 Reveals a Tetratricopeptide Repeat-like Fold and Provides
Insights into PP2A Regulation. Biochemistry 46: 8807–8815.
55. Prickett TD, Brautigan DL (2004) Overlapping binding sites in protein
phosphatase 2A for association with regulatory A and alpha-4 (mTap42)
subunits. J Biol Chem 279: 38912–38920.
56. Groves MR, Hanlon N, Turowski P, Hemmings BA, Barford D (1999) The
structure of the protein phosphatase 2A PR65/A subunit reveals the
conformation of its 15 tandemly repeated HEAT motifs. Cell 96: 99–110.
57. Trockenbacher A, Suckow V, Foerster J, Winter J, Krauss S, et al. (2001) MID1,
mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase
2A for degradation. Nat Genet 29: 287–294.
58. Tao H, Simmons BN, Singireddy S, Jakkidi M, Short KM, et al. (2008)
Structure of the MID1 tandem B-boxes reveals an interaction reminiscent of
intermolecular ring heterodimers. Biochemistry 47: 2450–2457.
59. Jo S, Vargyas M, Vasko-Szedlar J, Roux B, Im W (2008) PBEQ-Solver for
online visualization of electrostatic potential of biomolecules. Nucleic acids
research 36: W270–275.
60. Im W, Beglov D, Roux B (1998) Continuum Solvation Model: Computation of
Electrostatic Forces from Numerical Solutions to the Poisson-Boltzmann
Equation. Computer Physics Communications 111: 59–75.
NMR Structure of alpha4 C-Terminus
PLoS ONE | www.plosone.org 12 December 2011 | Volume 6 | Issue 12 | e28877